Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 12
- +2 vs. Q1 2023
- Portfolio value
- $389.1M
- +$275.2M (+241.4%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 246,250 | $109.2M | 28.1% | +246,250 | New | History |
| iShares MSCI India ETF46429B598 | ETF | 2,425,144 | $106.0M | 27.2% | +1,225,000+102.1% | Added | – |
| GLDSPDR Gold Trust | ETF | 555,000 | $98.9M | 25.4% | +555,000 | New | History |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $17.9M | 4.6% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,545,242 | $15.9M | 4.1% | +208,333+8.9% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $11.1M | 2.8% | +312,500+24.8% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 571,233 | $10.7M | 2.7% | +138,333+32.0% | Added | History |
| ALECAlector, Inc. | COM | 980,894 | $5.90M | 1.5% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 747,550 | $5.80M | 1.5% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 915,705 | $5.38M | 1.4% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 746,674 | $1.93M | 0.5% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 802,963 | $441.6K | 0.1% | 00.0% | Unchanged | History |